Interestingly, a peptide inhibiting RHOA activation by GEF-H1 has been shown to inhibit blood vessel leakage in a mouse model of uveitis (Mills et al., 2022), opening the door to a new therapeutic approach. The gene discussed is RHOA; the disease is uveitis.